Screener
Madrigal Pharmaceuticals, Inc. MDGL Intangibles (Net)
Intangibles (Net) at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.
The source filing: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed July 30, 2026.
- Filed
- Jul 30, 2026, 9:06 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050845
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Prepaid expenses and other current assets | 68,570 | 47,804 |
| Total current assets | 1,199,180 | 1,245,770 |
| Property and equipment, net | 11,592 | 1,499 |
| Intangible assets, net | 7,187 | 7,381 |
| Operating lease right-of-use assets | 5,578 | 4,939 |
| Other noncurrent assets | 21,108 | — |
| Total assets | $1,244,645 | $1,259,589 |
| Liabilities and Stockholders’ Equity |
Item 1. Financial Statements (Unaudited):
FAQ
- What is Madrigal Pharmaceuticals, Inc.'s intangibles (net)?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported intangibles (net) of $7.19M in Q2 2026.
- How has Madrigal Pharmaceuticals, Inc.'s intangibles (net) changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s intangibles (net) increased by 58.0% year-over-year, from $4.55M to $7.19M.
- What does intangibles (net) mean?
- Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.
Ask your AI about Madrigal Pharmaceuticals, Inc.'s intangibles (net).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude